The Mount Sinai Department of Dermatology
The Mount Sinai Department of Dermatology is dedicated to delivering superior, comprehensive dermatologic care, exceeding our patients’ expectations in service and satisfaction, and advancing the science of dermatology through research and education.
Our department consistently demonstrates excellence in research and high-level expertise in treating such conditions as:
- Skin cancer
- Mycosis fungoides (cutaneous T-cell lymphoma)
- Medical, surgical, and cosmetic dermatology
Thirteen faculty members see patients at the Faculty Practice Associates building at 5 East 98th Street in New York City. We also have five part-time chiefs at our affiliate hospitals, where we run the dermatology departments:
- Elmhurst General Hospital
- North General Hospital
- Queens General Hospital
- St. Barnabas Hospital
- Refuah Health Center
Our faculty use telemedicine to help diagnose complex dermatologic problems at remote sites. We also provide and receive referrals for more than 100 affiliated dermatologists in New York and nationwide.
Our department has developed a number of commonly prescribed treatments for such dermatologic disorders as psoriasis, eczema, vitiligo, and skin cancers. The department's phototherapy unit, which administers approximately 12,000 phototherapy treatments annually, is one of the largest in the nation.
We are one of only a few dermatology departments to have an infusion center for the treatment of bullous diseases, psoriasis, and other ailments such as pyoderma gangrenosum. Our department has an active patch test clinic and a number of lasers and devices for the treatment of psoriasis, vitiligo, and precancerous skin lesions known as actinic keratoses.
The Department of Dermatology has one of the largest and most successful programs for skin cancer surgery in the nation, and we are one of the first dermatology departments with a procedural dermatology fellowship.
Members of our faculty are among the best-known cosmetic dermatologists in the nation, and visiting fellows from around the world come to our department for the opportunity to gain insight into these cosmetic procedures. Fillers (various forms of collagen, Restylane, Juvederm, Perlane, Radiesse, and Sculptra), botulinum toxin, laser treatments, peels, and sclerotherapy (injection of leg veins) are among the many procedures performed daily in our cosmetic dermatology program.
Our faculty see more than 60,000 biopsy specimens annually.
The Department of Dermatology has an active clinical trials unit with three fellows and numerous study coordinators. Our clinical trials unit has made significant contributions to the treatment of dermatologic disease, including:
- Identifying the usefulness of imiquimod for the treatment of precancerous and cancerous skin lesions
- Being the first to use topical calcineurin inhibitors for the treatment of psoriasis on sensitive skin sites
- Identifying a number of topical drug interactions that have impacted how treatments are applied to the skin
- Being among the first to identify interactions between topically applied medications and phototherapy
Clinical trials available
Our clinical trials unit has been among the research leaders in biologic therapies for psoriasis and other disorders. We have active, ongoing clinical trials in:
- Actinic keratoses (precancerous skin lesions)
- Skin cancers that include basal cell carcinoma
- Psoriasis, eczema, acne, and numerous other disorders
The Department of Dermatology has funded a melanoma center, and we are one of only a small number of programs in the country with photographic mole-mapping technology. We employ advanced, noninvasive techniques for the diagnosis of melanoma, including innovative mole-scanning devices that help to diagnose melanomas early in susceptible patients.
One Gustave L. Levy Place
New York, NY 10029